| Drug Type Small molecule drug, Liposomal Drug | 
| Synonyms L-608 | 
| Target | 
| Action agonists | 
| Mechanism PGI2 receptor agonists(Prostanoid IP receptor agonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Pulmonary Arterial Hypertension | Phase 1 | New Zealand  | 11 Apr 2025 | 





